Latest News - Earnings & Financials

Tuesday, August 08, 2017 | Earnings & Financials, Aerie Pharmaceuticals

Aerpio Pharmaceuticals Commences Trading on the OTCQB Market

Aerpio Pharmaceuticals announced that shares of the company’s common stock have been cleared for trading on the OTC Market Group's OTCQB market in the United States. Shares of Aerpio’s…

Read the full story

Friday, August 04, 2017 | Earnings & Financials, Regeneron Pharmaceuticals

Regeneron's Second-Quarter Revenue Rises 21 Percent on Higher Eylea Sales

Regeneron Pharmaceuticals announced that revenue for the second quarter jumped 21 percent to $1.5 billion, beating analyst estimates of $1.4 billion, fuelled by 11-percent growth in Eyl…

Read the full story

Wednesday, July 26, 2017 | Clinical Trials, Earnings & Financials, AMD, Ophthotech

Ophthotech Expands Focus with Development for Ophthalmic Orphan Diseases

Ophthotech announced that the company is pursuing a strategy to leverage its clinical experience and retina expertise to identify and develop therapies to treat multiple orphan ophthalmic diseases for…

Read the full story

Wednesday, July 26, 2017 | Earnings & Financials, Kala Pharmaceuticals 

Kala Pharmaceuticals Announces Close of Initial Public Offering and Exercise of Underwriters’ Option

Kala Pharmaceuticals announced the closing of its initial public offering of 6,900,000 shares of common stock, including the underwriters’ exercise in full of their option to purchase an additio…

Read the full story

Monday, July 24, 2017 | Earnings & Financials, Allegro Ophthalmics

Allegro Ophthalmics Secures $10.7 Million in Private Financing

Allegro Ophthalmics announced the completion of a private round of equity financing for $10.7 million. With this infusion of capital, the company is positioned to reach future corporate milestones. Th…

Read the full story

Thursday, July 20, 2017 | Earnings & Financials, Kala Pharmaceuticals 

Kala Pharmaceuticals Announces Pricing of Initial Public Offering

Kala Pharmaceuticals announced that is has priced its initial public offering of 6,000,000 shares of its common stock at a public offering price of $15 per share, for aggregate gross proceeds of appro…

Read the full story

Tuesday, July 18, 2017 | Earnings & Financials, Alcon

Latest Novartis Earnings Show Signs of a Rebound at Alcon

As part of its second quarter earnings, Novartis reported that sales at its Alcon unit accelerated in the second quarter. Novartis Chief Executive Joe Jimenez said the results increase the number of o…

Read the full story

Tuesday, June 27, 2017 | Earnings & Financials

NuEyes Secures Funding by Early Stage Venture Capital Firm, Arab Angel and Strategic Partners

NuEyes Technologies announced that it has secured a round of funding to fuel its growth in helping the legally blind live more independent lives. NuEyes works closely with ODG (Osterhout Design G…

Read the full story

Tuesday, May 30, 2017 | Earnings & Financials

TearClear Completes $4.5 Million Series A Financing and Introduces Leadership Team of Accomplished Ophthalmology Veterans

TearClear, an eye health technology company focused on developing a safe and reliable means of delivering preservative-free topical ophthalmic drugs, announced the completion of its Series A financing…

Read the full story

Friday, May 26, 2017 | Earnings & Financials, Aerie Pharmaceuticals

Aerie Pharmaceuticals Announces Public Offering of Common Stock

Aerie Pharmaceuticals announced that it has commenced a registered underwritten public offering of $50 million of shares of its common stock. Cantor Fitzgerald & Co. is acting as the sole bookr…

Read the full story

Monday, May 22, 2017 | Earnings & Financials, Eyegate Pharmaceuticals

EyeGate Receives Milestone Payment from Valeant for EGP-437 for Postoperative Ocular Inflammation and Pain

EyeGate Pharmaceuticals announced that it has received its first development milestone from a subsidiary of Valeant under the company's license agreement with Valeant, pursuant to which EyeGate …

Read the full story

Monday, May 22, 2017 | Earnings & Financials, NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Receives Noncompliance Notice from NYSE

NovaBay Pharmaceuticals announced receipt of a letter from NYSE MKT LLC on May 16, 2017, stating that it is not in compliance with the continued listing standards (requiring stockholders’ equity…

Read the full story

Wednesday, May 17, 2017 | Earnings & Financials, ONL Therapeutics

ONL Therapeutics Closes Series A Financing to Support Development of Novel Retinal Cell Protection Platform for Treatment of Ocular Diseases

ONL Therapeutics announced that it has closed a $4.25 million Series A round of fundraising, which, combined with the recently announced $1 million grant from the National Eye Institute, will primaril…

Read the full story

Thursday, May 11, 2017 | Acquisitions/Mergers, Earnings & Financials

Lensar and PDL Biopharma Complete Strategic Financial Restructuring of Lensar

Lensar and PDL BioPharma announced the completion of Lensar’s financial restructuring with a court-approved exit plan finalized on May 11, 2017. As part of the plan, PDL will convert most of its…

Read the full story

Thursday, May 04, 2017 | Earnings & Financials, Avedro

Avedro Launches Comprehensive Effort to Secure Coverage and Facilitate Reimbursement of FDA-Approved Corneal Cross-Linking Procedure

Avedro announced a comprehensive effort to secure commercial coverage and support reimbursement of Photrexa Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution), Photrexa (ribofl…

Read the full story
Load More